Advanced search×

[Long-term results of iridocyclectomy for iris tumours]

Klin Monbl Augenheilkd 225(12):1045-50 (2008) PMID 19085783

BACKGROUND: The aim of this study was to evaluate the long-term survival rate and functional results after iridocyclectomy. PATIENTS AND METHOD: Between 1980 and 2002 39 patients (26 female and 13 male) ranging in age from 20 to 79 years (median m = 58 years) underwent iridocyclectomy for a tumour of periphery iris by means of a lamellar technique or by trepanating. Follow-up time ranged from 3 months to 24 years (m = 11.2 years). RESULTS: In 21 cases (54 %) there was a malignant tumour including 20 melanomas (mostly spindle-cell and mixed-cell melanomas) and one filiae of a bronchial carcinoma. There was a variety of histopathological entities in the 18 benign lesions (46 %). Naevi were the most frequent. The outcome was satisfactory: 57 % of the patients kept a visual acuity of > 0.5. Three eyes had to be enucleated. The rate of recurrence was 10 % (4 cases). The Kaplan-Meyer estimate for the 10-year-survival of the patients with a malignant iris tumour was 77 %. Two patients died of metastic melanoma following spindle-cell and mixed-cell melanoma. CONCLUSION: The long-term functional results after Iridocyclectomy are good, whereas complications and recurrences are rare. The 10-year-survival is high. Over a long period iridocyclectomy is a recommendable surgical procedure for removal of progredient tumours of the anterior uvea.

DOI: 10.1055/s-2008-1027609
Version: za2963e q8za4 q8zbf q8zc7 q8zd7 q8ze4 q8zf9 q8zg3

Similar articles you may find interesting…

  1. Cytokine and molecular analyses of intraocular lymphoma.

    Ocul Immunol Inflamm 17(3):142-7 (2009) PMID 19585355

    Purpose: The authors investigate the efficacy of using the cytokine levels and clonal heavy-chain immunoglobulin (IgH) gene rearrangements in the vitreous as adjunctive tools to diagnose intraocular lymphoma (IOL). Methods: The IL-10 and IL-6 levels and IgH gene rearrangements were anal...
  2. Iritis and iris neoplasm as the presenting signs of esophageal squamous cell carcinoma.

    Can J Ophthalmol 44(4):465-6 (2009) PMID 19606176

  3. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine.

    Hepatogastroenterology 56(93):1157-62 (2009) PMID 19760961

    Present data demonstrate, in agreement with the literature, the effectiveness of HAI in the treatment of uveal melanoma metastatic to the liver. The HAI of combination of cisplatin, vinblastine and dacarbazine seems to have similar efficacy as other HAI regimens....